Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

160 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Clonal Evolution and Heterogeneity of Osimertinib Acquired Resistance Mechanisms in EGFR Mutant Lung Cancer.
Roper N, Brown AL, Wei JS, Pack S, Trindade C, Kim C, Restifo O, Gao S, Sindiri S, Mehrabadi F, El Meskini R, Ohler ZW, Maity TK, Venugopalan A, Cultraro CM, Akoth E, Padiernos E, Chen H, Kesarwala A, Smart DK, Nilubol N, Rajan A, Piotrowska Z, Xi L, Raffeld M, Panchenko AR, Sahinalp C, Hewitt S, Hoang CD, Khan J, Guha U. Roper N, et al. Among authors: nilubol n. Cell Rep Med. 2020 Apr 21;1(1):100007. doi: 10.1016/j.xcrm.2020.100007. Cell Rep Med. 2020. PMID: 32483558 Free PMC article. Clinical Trial.
Immune signature of pheochromocytoma and paraganglioma in context of neuroendocrine neoplasms associated with prognosis.
Ghosal S, Vanova KH, Uher O, Das S, Patel M, Meuter L, Huynh TT, Jha A, Talvacchio S, Knue M, Prodanov T, Zeiger MA, Nilubol N, Taieb D, Crona J, Shankavaram UT, Pacak K. Ghosal S, et al. Among authors: nilubol n. Endocrine. 2023 Jan;79(1):171-179. doi: 10.1007/s12020-022-03218-1. Epub 2022 Nov 12. Endocrine. 2023. PMID: 36370152 Free PMC article.
Preclinical Models of Adrenocortical Cancer.
Sedlack AJH, Hatfield SJ, Kumar S, Arakawa Y, Roper N, Sun NY, Nilubol N, Kiseljak-Vassiliades K, Hoang CD, Bergsland EK, Hernandez JM, Pommier Y, Del Rivero J. Sedlack AJH, et al. Among authors: nilubol n. Cancers (Basel). 2023 May 23;15(11):2873. doi: 10.3390/cancers15112873. Cancers (Basel). 2023. PMID: 37296836 Free PMC article. Review.
New Therapies for Advanced Thyroid Cancer.
Laha D, Nilubol N, Boufraqech M. Laha D, et al. Among authors: nilubol n. Front Endocrinol (Lausanne). 2020 May 22;11:82. doi: 10.3389/fendo.2020.00082. eCollection 2020. Front Endocrinol (Lausanne). 2020. PMID: 32528402 Free PMC article. Review.
Germline SUCLG2 Variants in Patients With Pheochromocytoma and Paraganglioma.
Hadrava Vanova K, Pang Y, Krobova L, Kraus M, Nahacka Z, Boukalova S, Pack SD, Zobalova R, Zhu J, Huynh TT, Jochmanova I, Uher O, Hubackova S, Dvorakova S, Garrett TJ, Ghayee HK, Wu X, Schuster B, Knapp PE, Frysak Z, Hartmann I, Nilubol N, Cerny J, Taieb D, Rohlena J, Neuzil J, Yang C, Pacak K. Hadrava Vanova K, et al. Among authors: nilubol n. J Natl Cancer Inst. 2022 Jan 11;114(1):130-138. doi: 10.1093/jnci/djab158. J Natl Cancer Inst. 2022. PMID: 34415331 Free PMC article.
Current Status and Future Targeted Therapy in Adrenocortical Cancer.
Alyateem G, Nilubol N. Alyateem G, et al. Among authors: nilubol n. Front Endocrinol (Lausanne). 2021 Mar 1;12:613248. doi: 10.3389/fendo.2021.613248. eCollection 2021. Front Endocrinol (Lausanne). 2021. PMID: 33732213 Free PMC article. Review.
160 results